Electroacupuncture to Assist Ventilator Weaning in Severe Stroke
Launched by THE SECOND AFFILIATED HOSPITAL, GUANGZHOU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE · Mar 24, 2021
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether electroacupuncture can help patients with severe strokes who are on ventilators to breathe on their own again. Electroacupuncture is a treatment that uses small electrical currents with needles placed at specific points on the body, which some studies suggest may aid recovery. The trial is currently recruiting participants aged between 18 and 75 years who have had a stroke within the last week and are receiving mechanical ventilation, which means they need help to breathe.
To be eligible for the study, participants must show certain signs of stroke severity and be able to give consent, either personally or through a family member. Unfortunately, individuals who are expected to need a ventilator for less than 24 hours, have been on one for more than 72 hours, or have certain medical conditions or recent surgeries cannot participate. If you join the trial, you will receive the electroacupuncture treatment as part of your care, and the researchers will closely monitor your progress to see how it affects your ability to breathe without the ventilator.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age ≥ 18 years and ≤ 75 years ;
- • 2. within 7 days after the onset of stroke (ischemic or hemorrhagic), confirmed by a computed tomography (CT) or magnetic resonance imaging (MRI) scan of the brain;
- • 3. GCS on admission ≤ 12 or NIHSS on admission ≥ 11 or APACHEⅡ ≥ 15;
- • 4. received mechanical ventilation;
- • 5. written informed consent is able to be obtained directly from the patient or an appropriate surrogate, based on local ethics committee recommendations.
- Exclusion Criteria:
- • 1. expected to be ventilated for \< 24 h;
- • 2. already ventilated for \> 72 h;
- • 3. GCS \<5;
- • 4. with unstable vital signs and requiring the use of vasoactive agents;
- • 5. concomitant medical illness that would interfere with the outcome assessments and/or follow-up;
- • 6. had spinal cord injury above T8 level, or lower motor neuron impairment, or neuromuscular junction impairment,or chest wall deformities, or chest wall injuries within 6 months, or chest or abdominal surgery within 4 week, or were pregnant;
- • 7. had acute skin injury on the selected acupoints;
- • 8. currently participating in other investigational trials.
About The Second Affiliated Hospital, Guangzhou University Of Traditional Chinese Medicine
The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine is a leading institution dedicated to advancing healthcare through the integration of traditional Chinese medicine and modern medical practices. As a prominent clinical trial sponsor, the hospital focuses on innovative research and development aimed at enhancing therapeutic approaches and improving patient outcomes. With a commitment to evidence-based practices, the hospital collaborates with various stakeholders to conduct rigorous clinical trials that explore the efficacy and safety of traditional and integrative treatment modalities. Its multidisciplinary team of experts is dedicated to fostering advancements in medical science while promoting holistic patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Lixin Wang, PhD
Study Director
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials